2. Metabolic Enzyme/Protease Immunology/Inflammation Apoptosis Cell Cycle/DNA Damage Epigenetics
  3. Indoleamine 2,3-Dioxygenase (IDO) Interleukin Related Apoptosis Caspase PARP
  4. IDO1-IN-34

IDO1-IN-34 is a selective IDO1 inhibitor with an IC50 of 0.093 μM. IDO1-IN-34 exhibits cytotoxicity against various cancer cell lines. IDO1-IN-34 inhibits the kynurenine (kynurenine) pathway and activates IL-2. IDO1-IN-34 induces cell apoptosis via the endogenous mitochondrial pathway, while increasing the levels of cytochrome c, caspase-3, caspase-9 and PARP-1. IDO1-IN-34 can be used for research on liver cancer, lung cancer, breast cancer, prostate cancer, colon cancer and leukemia.

For research use only. We do not sell to patients.

IDO1-IN-34

IDO1-IN-34 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

IDO1-IN-34 Related Antibodies

Top Publications Citing Use of Products

View All Indoleamine 2,3-Dioxygenase (IDO) Isoform Specific Products:

View All Isoforms
IDO1 IDO2 IDO

View All Interleukin Related Isoform Specific Products:

View All Isoforms
IL-1 IL-2 IL-3 IL-4 IL-5 IL-6 IL-8 IL-10 IL-12 IL-13 IL-15 IL-17 IL-23 IL-7 IL-33 IL-22 IL-18

View All Caspase Isoform Specific Products:

View All Isoforms
Caspase 1 Caspase 2 Caspase 3 Caspase 4 Caspase 5 Caspase 6 Caspase 7 Caspase 8 Caspase 9 Caspase 10 Caspase 12 Caspase Caspase 11 Caspase-13

View All PARP Isoform Specific Products:

View All Isoforms
PARP PARP1 PARP2 PARP3 PARP4 TNKS1/PARP5A TNKS2/PARP5B PARP7 PARP10 PARP14 PARP15 PARP12 PARP16

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

IDO1-IN-34 is a selective IDO1 inhibitor with an IC50 of 0.093 μM. IDO1-IN-34 exhibits cytotoxicity against various cancer cell lines. IDO1-IN-34 inhibits the kynurenine (kynurenine) pathway and activates IL-2. IDO1-IN-34 induces cell apoptosis via the endogenous mitochondrial pathway, while increasing the levels of cytochrome c, caspase-3, caspase-9 and PARP-1. IDO1-IN-34 can be used for research on liver cancer, lung cancer, breast cancer, prostate cancer, colon cancer and leukemia[1].

IC50 & Target[1]

IDO1

0.093 μM (IC50)

IL-2

 

Caspase-9

 

Caspase-3

 

PARP-1

 

In Vitro

IDO1-IN-34 (Compound 3b) (0.1-100 μM; 48 h) exhibits selective cytotoxicity against a variety of cancer cell lines, with the highest potency against HepG2 cells (GI50 = 0.72 μM). It shows extremely low cytotoxicity against non-cancerous Vero cells, resulting in a selectivity index of 121.58 for HepG2 cells[1].
IDO1-IN-34 (0.03-0.3 μM; 24 h) dose-dependently reduces kynurenine production in IFN-γ-stimulated SK-OV-3 cells and reverses IDO1-mediated immunosuppression[1].
IDO1-IN-34 (0.03-0.3 μM; 2 days) restores T cell activation in a dose-dependent manner and increases IL-2 expression in an IDO1-inhibited SK-OV-3/Jurkat T cell co-culture system[1].
IDO1-IN-34 (0.36-0.72 μM; 24 h) induces apoptosis in HepG2 cells in a dose-dependent manner[1].
IDO1-IN-34 (0.36-0.72 μM; 48 h) dose-dependently activates the endogenous mitochondrial apoptotic pathway in HepG2 cells, as evidenced by increased levels of cleaved caspase-3, cleaved caspase-9, cleaved PARP-1, and cytochrome c, without activating cleaved caspase-8, a marker of the exogenous apoptotic pathway[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

IDO1-IN-34 Related Antibodies

Cell Cytotoxicity Assay[1]

Cell Line: HepG2, A549, MCF-7, PC-3, HT-29, K562, Vero
Concentration: 0.1-100 μM
Incubation Time: 48 h
Result: Exhibited a GI50 of 0.72 μM against HepG2 liver cancer cells.
Exhibited a GI50 of 3.02 μM against A549 lung cancer cells.
Exhibited a GI50 of 4.55 μM against MCF-7 breast cancer cells.
Exhibited a GI50 of 3.28 μM against PC-3 prostate cancer cells.
Exhibited a GI50 of 6.04 μM against HT-29 colon cancer cells.
Exhibited a GI50 of 10.27 μM against K562 leukemia cells.
Exhibited a GI50 of 87.54 μM against non-cancerous Vero cells.
Yielded selectivity indices of 121.58 (HepG2), 28.98 (A549), 19.23 (MCF-7), 26.68 (PC-3), 14.49 (HT-29), and 8.52 (K562).

ELISA Assay[1]

Cell Line: SK-OV-3/Jurkat T-cell co-cultures
Concentration: 0.03, 0.1, 0.3 μM
Incubation Time: 2 days
Result: Increased IL-2 levels to 416.59 pg/mL at 0.03 μM compared to 161.03 pg/mL in IFN-γ-only treated co-cultures.
Increased IL-2 levels to 648.84 pg/mL at 0.1 μM compared to 161.03 pg/mL in IFN-γ-only treated co-cultures.
Increased IL-2 levels to 865.67 pg/mL at 0.3 μM compared to 161.03 pg/mL in IFN-γ-only treated co-cultures.

Apoptosis Analysis[1]

Cell Line: HepG2 liver cancer cells
Concentration: 0.36 μM, 0.72 μM
Incubation Time: 24 h
Result: Increased total apoptosis (early + late) to 36.16% at 0.36 μM compared to 9.13% in control cells.
Increased total apoptosis (early + late) to 59.33% at 0.72 μM compared to 9.13% in control cells.

Western Blot Analysis[1]

Cell Line: HepG2 liver cancer cells
Concentration: 0.36 μM, 0.72 μM
Incubation Time: 48 h
Result: Dose-dependently increased levels of cytochrome c, cleaved caspase-3, cleaved caspase-9, and cleaved PARP-1.
Dose-dependently reduced levels of total caspase-3, total caspase-9, and total PARP-1.
Did not increase cleaved caspase-8 levels at either concentration tested.
Molecular Weight

527.19

Formula

C18H10BrF7N4O2
SMILES

O=C(C1=NNN=C1C2=CC(C(F)(F)F)=CC(Br)=C2)NC3=CC=C(C(OCC(F)(F)F)=C3)F
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

IDO1-IN-34 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

IDO1-IN-34Indoleamine 2,3-Dioxygenase (IDO)Interleukin RelatedApoptosisCaspasePARPILpoly ADP ribose polymerasekynurenine pathwayintrinsic mitochondrial pathwayIL-2HepG2 cellscaspase-9caspase-3cytochrome cPARP-1IDO1SK-OV-3 cellsInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
IDO1-IN-34
Cat. No.:
HY-183317
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.